Results of preoperative hepatic arterial infusion chemotherapy in patients undergoing liver resection for colorectal liver metastases

Annals of Surgical Oncology

Volumn 15, Issue 6, 2008, Pages 1661-1669

  Pulitanò, Carlo ^a   Arru, Marcella ^a   Catena, Marco ^a   Guzzetti, Eleonora ^a   Vitali, Giordano ^a   Ronzoni, Monica ^a   Venturini, Massimo ^a   Villa, Eugenio ^a   Ferla, Gianfranco ^a   Aldrighetti, Luca ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Colorectal liver metastases; FUDR; Hepatic arterial infusion chemotherapy; Liver resection; Liver surgery; Neoadjuvant chemotherapy; Preoperative chemotherapy

Indexed keywords

DEXAMETHASONE; ENOXAPARIN; FLOXURIDINE;

AGED; ARTICLE; BILE DUCT FISTULA; CANCER PATIENT; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GASTROENTERITIS; HEPATITIS; HUMAN; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; SCLEROSIS; SEPSIS; THROMBOSIS; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; COLORECTAL NEOPLASMS; FEASIBILITY STUDIES; FEMALE; FLOXURIDINE; HEPATECTOMY; HEPATIC ARTERY; HUMANS; INFUSIONS, INTRA-ARTERIAL; LIVER NEOPLASMS; MALE; MIDDLE AGED; PREOPERATIVE CARE;

EID: 43449137551     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-008-9882-5     Document Type: Article

References (32)

1. Strangl Altendorf-Hofmann A, Charnley RM, Scheele J. Factors influencing the natural history of colorectal liver metastases. Lancet 1994; 343:1405-10.
2. Scheele J, Stangl R, Altendorf-Hofmann A. Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg 1990; 77:1241-6.
3. Leonard GD, Brenner B, Kemeny NE. Neoadjuvant chemotherapy before liver resection for patients with unresectable liver metastases from colorectal carcinoma. J Clin Oncol 2005; 23:2038-48.
4. Van Cutsem E, Nordlinger B, Rene Adam R, et al. Towards a pan-European consensus on the treatment of patients with colorectal liver metastases. Eur J Cancer 2006 42:2212-21.
5. Sullivan RD, Norcross JW, Watkins E. Chemotherapy of metastatic liver cancer by prolonged hepatic-artery infusion. N Engl J Med 1964; 270:321-7.
6. Collins JM. Pharmacologic rationale for regional drug delivery. J Clin Oncol 1984; 2:498-504.
7. Elias D, Lasser P, Rougier P, et al. Frequency, technical aspects, results, and indications of major hepatectomy after prolonged intra-arterial hepatic chemotherapy for initially unresectable hepatic tumors. J Am Coll Surg 1995; 180:213-9.
8. Skitzki JJ, Chang AE. Hepatic artery chemotherapy for colorectal liver metastases: technical considerations and review of clinical trials. Surg Oncol 2002; 11:23-35.
9. Link KH, Pillasch J, Formentini E, et al. Down staging by regional chemotherapy of nonresectable isolated colorectal liver metastases. Eur J Surg Oncol 1999; 25:381-8.
10. Meric F, Patt YZ, Curley SA, et al. Surgery after downstaging of unresectable hepatic tumors with intra-arterial chemotherapy. Ann Surg Oncol 2000; 7:490-5.
11. Clavien PA, Selzner N, Morse M, et al. Downstaging of hepatocellular carcinoma and liver metastases from colorectal cancer by selective intra-arterial chemotherapy. Surgery 2002; 131:433-42.
12. Milandri C, Calazolari F, Giampalma E, et al. Combined treatment of inoperable liver metastases from colorectal cancer. Tumori 2003; 89:112-4.
13. Recommendations for clinical practice: therapeutic management of hepatic metastases from colorectal cancers. Gastroenterol Clin Biol 2003; Special issue II
14. Aldrighetti L, Arru M, Angeli E, et al. Percutaneous vs. surgical placement of hepatic artery indwelling catheters for regional chemotherapy. Hepatogastroenterology 2002; 49:513-7.
15. Venturini M, Angeli E, Salvioni M, et al. Complications after percutaneous transaxillary implantation of a catheter for intraarterial chemotherapy of liver tumors: clinical relevance and management in 204 patients. Am J Roentgenol 2004; 182:1417-26.
16. Aldrighetti L, Pulitanò C, Arru M, et al. " Technological" approach versus clamp crushing technique for hepatic parenchymal transection: a comparative study. J Gastrointest Surg 2006;10:974-9.
17. Pulitanò C, Arru M, Bellio L, et al. A risk score system for predicting perioperative blood transfusion in liver surgery. Br J Surg 2007; 94:860-5.
18. Terminology Committee of the international Hepato-Pancreato-Biliary Association. The IHPBA Brisbane 2000 terminology of liver anatomy and resections. HPB Surg 2000; 2:333-9.
19. Aldrighetti L, Pulitanò C, Arru M, et al. Impact of preoperative steroids administration on ischemia-reperfusion injury and systemic responses in liver surgery: a prospective randomized study. Liver Transplant 2006; 12:941-9.
20. Emori TG, Culver DH, Horan TC, et al. National Nosocomial Infections Surveilance System (NNIS): description of surveilance methods. Am J Infect Control 1991; 19:13-5.
21. Fong Y, Fortner J, Sun RL, et al. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999; 230:309-18.
22. Adam R, Delvart V, Pascal G, et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 2004; 240:644-57.
23. Giacchetti S, Perpoint B, Zidani R, et al. Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil leucovorin as first-line treatment of metastatic colorectal cancer. J Clin Oncol 2000; 18:136-47.
24. Fernandez FG, Ritter J, Linehan DC, et al. Effect of steatohepatitis associated with irinotecan or oxaliplatin pre-treatment on resectability of hepatic colorectal metastases. J Am Coll Surg 2005; 200:845-53.
25. Bilchik AJ, Poston G, Curley SA, et al. Neoadjuvant chemotherapy for metastatic colon cancer: a cautionary note. J Clin Oncol 2005; 23:9073-8.
26. Karoui M, Penna C, Amin-Hashem M, et al. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 2006; 243:1-7.
27. Kemeny NE, Steiter K, Niedzwiecki D, et al. A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer. Cancer 1992; b69:327-34.
28. Tanaka K, Shimada H, Kubota K, et al. Effectiveness of prehepatectomy intraarterial chemotherapy for multiple bilobar colorectal cancer metastases to the liver: a clinicopathologic study of peritumoral vasculobiliary invasion. Surgery 2005; 137:156-64.
29. Kemeny NE, Niedzwiecki D, Hollis DR, et al. Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). J Clin Oncol 2006; 24:1395-403.
30. Kemeny NE, Fong Y, Jarnagin W, et al. A phase I trial of systemic oxaliplatin combinations with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer. J Clin Oncol 2005; 23:4888-96.
31. Kemeny NE, Gönen M, Sullivan D, et al. Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer. J Clin Oncol 2001; 19:2687-95.
32. Ducreux M, Ychou M, Laplanche A, et al. Combination of hepatic arterial oxaliplatin infusion and intravenous chemotherapy with leucovorin and fluorouracil in colorectal cancer patients with isolated inoperable hepatic metastases. J Clin Oncol 2005; 23:4881-87.